Le choc septique de l'adulte en France : vingt ans de données épidémiologiques, Réanimation. 1 mai, vol.24, issue.3, pp.303-312, 2015. ,
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3), JAMA. 23 févr, vol.315, issue.8, pp.801-811, 2016. ,
, SepNet Critical Care Trials Group. Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study, Intensive Care Med. 1 déc, vol.42, issue.12, pp.1980-1989, 2016.
Epidemiologic trends of sepsis in western countries, Ann Transl Med. 13 sept, vol.4, issue.17, p.2, 2016. ,
Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock, N Engl J Med, vol.345, issue.19, pp.1368-77, 2001. ,
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016, Crit Care Med. mars, vol.45, issue.3, pp.486-552, 2017. ,
Depression, Posttraumatic Stress Disorder, and Functional Disability in Survivors of Critical Illness: results from the BRAIN ICU (Bringing to light the Risk Factors And Incidence of Neuropsychological dysfunction in ICU survivors) Investigation: A Longitudinal Cohort Study, Lancet Respir Med. mai, vol.2, issue.5, pp.369-79, 2014. ,
Extended Mortality and Chronic Kidney Disease After Septic Acute Kidney Injury, J Intensive Care Med. 1 juin, vol.35, issue.6, pp.527-562, 2020. ,
Early hypertension after vasopressor weaning during septic shock: associated factors and prognostic significance, Minerva Anestesiol, vol.84, issue.2, p.8, 2018. ,
Actual incidence of global left ventricular hypokinesia in adult septic shock, Crit Care Med. juin, vol.36, issue.6, pp.1701-1707, 2008. ,
Heart failure and sepsis: practical recommendations for the optimal management, Heart Fail Rev. 1 mars, vol.25, issue.2, pp.183-94, 2020. ,
Levosimendan for the Prevention of Acute Organ Dysfunction in Sepsis, N Engl J Med, vol.375, issue.17, pp.1638-1686, 2016. ,
Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction, J Am Coll Cardiol, vol.10, issue.2, pp.173-82, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01858896
Norepinephrine exerts an inotropic effect during the early phase of human septic shock, Br J Anaesth. 1 mars, vol.120, issue.3, pp.517-541, 2018. ,
Glycocalyx and sepsis-induced alterations in vascular permeability, Disponible sur, vol.19, 2015. ,
Bench to bedside review: therapeutic modulation of nitric oxide in sepsis-an update, Intensive Care Med Exp, vol.2, issue.2019 ,
Vasoplegia in patients with sepsis and septic shock: pathways and mechanisms, J Int Med Res. avr, vol.46, issue.4, pp.1303-1313, 2018. ,
KATP channel action in vascular tone regulation: from genetics to diseases, Sheng Li Xue Bao. 25 févr, vol.64, issue.1, pp.1-13, 2012. ,
Angiotensin in Critical Care, Crit Care. 20 mars, vol.22, issue.1, p.69, 2018. ,
Functional involvement of angiotensin AT2 receptor in adrenal catecholamine secretion in vivo, Can J Physiol Pharmacol. mai, vol.77, issue.5, pp.367-74, 1999. ,
Oxidative stress and vascular damage in hypertension, Curr Hypertens Rep. févr, vol.2, issue.1, pp.98-105, 2000. ,
Role of angiotensin II type 1 receptor in angiotensin II-induced cytokine production in macrophages, J Interferon Cytokine Res Off J Int Soc Interferon Cytokine Res. avr, vol.31, issue.4, pp.351-61, 2011. ,
Angiotensin II-induced mononuclear leukocyte interactions with arteriolar and venular endothelium are mediated by the release of different CC chemokines, J Immunol Baltim Md, vol.176, issue.9, pp.5577-86, 1950. ,
Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo, Circulation, vol.100, issue.15, pp.1646-52, 1999. ,
Misdirected Sympathy: The Role of Sympatholysis in Sepsis and Septic Shock, J Intensive Care Med. févr, vol.33, issue.2, pp.74-86, 2018. ,
Inhibition of NF-kappaB activity prevents downregulation of alpha1-adrenergic receptors and circulatory failure during CLP-induced sepsis, Shock Augusta Ga. sept, vol.32, issue.3, pp.239-285, 2009. ,
Cytokines down-regulate alpha1-adrenergic receptor expression during endotoxemia, Crit Care Med. févr, vol.31, issue.2, pp.566-71, 2003. ,
Vasopressin Deficiency Contributes to the Vasodilation of Septic Shock, Circulation. 4 mars, vol.95, issue.5, pp.1122-1127, 1997. ,
Cytokine-mediated downregulation of vasopressin V1A receptors during acute endotoxemia in rats, Am J Physiol-Regul Integr Comp Physiol. 1 avr, vol.282, issue.4, pp.979-84, 2002. ,
The dissociation of renin and aldosterone during critical illness, J Clin Endocrinol Metab. mars, vol.64, issue.3, pp.592-597, 1987. ,
Hyperreninemic hypoaldosteronism: a possible etiological factor of septic shock-induced acute renal failure, Intensive Care Med, vol.29, issue.10, pp.1703-1712, 2003. ,
Renin-angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsis, Crit Care, vol.14, issue.1, p.24, 2010. ,
Implications of Plasma Renin Activity and Plasma Aldosterone Concentration in Critically Ill Patients with Septic Shock, Korean J Crit Care Med. 31 mai, vol.32, issue.2, pp.142-53, 2017. ,
Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock, Crit Care, vol.6, issue.2020 ,
Angiotensin II for the Treatment of Vasodilatory Shock, N Engl J Med. 3 août, vol.377, issue.5, pp.419-449, 2017. ,
Downregulation of angiotensin II type 1 receptors during sepsis. Hypertens Dallas Tex 1979, août, vol.38, issue.2, pp.177-82, 2001. ,
Blockade of multiple but not single cytokines abrogates downregulation of angiotensin II type-I receptors and anticipates septic shock, Cytokine. janv, vol.49, issue.1, pp.30-38, 2010. ,
The angiotensin II AT1 receptor-associated protein Arap1 is involved in sepsis-induced hypotension, Crit Care, vol.17, issue.4, p.130, 2013. ,
Sepsis in European intensive care units: results of the SOAP study, Crit Care Med. févr, vol.34, issue.2, pp.344-53, 2006. ,
Detection of Renal Blood Flow Abnormalities in Septic and Critically III Patients Using a Newly Designed Indwelling Thermodilution Renal Vein Catheter, Chest. juill, vol.98, issue.1, pp.170-179, 1990. ,
Measurement of renal blood flow by phasecontrast magnetic resonance imaging during septic acute kidney injury: A pilot investigation*, Crit Care Med. juin, vol.40, issue.6, pp.1768-76, 2012. ,
Acute kidney injury is associated with a decrease in cortical renal perfusion during septic shock, Crit Care, vol.15, 2018. ,
Renal perfusion evaluation with contrast-enhanced ultrasonography, Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -Eur Ren Assoc. févr, vol.27, issue.2, pp.674-81, 2012. ,
Histopathology of Septic Acute Kidney Injury: A Systematic Review of Experimental Data, Crit Care Med. sept, vol.44, issue.9, pp.897-903, 2016. ,
Kidney histopathology in lethal human sepsis, Crit Care. 27 déc, vol.22, issue.1, p.359, 2018. ,
Losartan reduces ensuing chronic kidney disease and mortality after acute kidney injury ,
AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney disease, Kidney Int. 1 févr, vol.89, issue.2, pp.363-73, 2016. ,
Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury, Kidney Int. 1 janv, vol.83, issue.1, pp.93-103, 2013. ,
Competing Actions of Type 1 Angiotensin II Receptors Expressed on T Lymphocytes and Kidney Epithelium during Cisplatin-Induced AKI, J Am Soc Nephrol JASN. août, vol.27, issue.8, pp.2257-64, 2016. ,
Recovery from renal ischemia-reperfusion injury is associated with altered renal hemodynamics, blunted pressure natriuresis, and sodium-sensitive hypertension, Am J Physiol -Regul Integr Comp Physiol, vol.297, issue.5, pp.1358-63, 2009. ,
Recovery from acute renal failure predisposes hypertension and secondary renal disease in response to elevated sodium, Am J Physiol Renal Physiol. juill, vol.293, issue.1, pp.269-278, 2007. ,
Th-17 cell activation in response to high salt following acute kidney injury is associated with progressive fibrosis and attenuated by AT-1R antagonism, Kidney Int, vol.88, issue.4, pp.776-84, 2015. ,
Three-year outcomes after acute kidney injury: results of a prospective parallel group cohort study, Disponible sur, vol.29 ,
Post-Acute Kidney Injury Proteinuria and Subsequent Kidney Disease Progression: The Assessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury (ASSESS-AKI) Study, JAMA Intern Med. 1 mars, vol.180, issue.3, pp.402-412, 2020. ,
The Incidence of Chronic Kidney Disease Three Years after Non-Severe Acute Kidney Injury in Critically Ill Patients: A Single-Center Cohort Study, Disponible sur, vol.8 ,
Elevated BP after AKI, J Am Soc Nephrol JASN. mars, vol.27, issue.3, pp.914-937, 2016. ,
Acute kidney injury in critically ill children and 5-year hypertension, Pediatr Nephrol Berl Ger. juin, vol.35, issue.6, pp.1097-107, 2020. ,
Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury, Intensive Care Med. mai, vol.44, issue.5, pp.598-605, 2018. ,
Renin-angiotensin-aldosterone system blockers after KDIGO stage 3 acute kidney injury: use and impact on 2-year mortality in the AKIKI trial, Crit Care. déc, vol.23, issue.1, p.148, 2019. ,
ESC/ESH Guidelines for the management of arterial hypertensionThe Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH), Eur Heart J. 1 sept, vol.39, issue.33, pp.3021-104, 2018. ,
Renin-Angiotensin System Blockade after Acute Kidney Injury (AKI) and Risk of Recurrent AKI, Clin J Am Soc Nephrol, vol.7, issue.2020, pp.26-34 ,
Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury, JAMA Intern Med. déc, vol.178, issue.12, pp.1681-90, 2018. ,
, AND TEMPORAL TRENDS SINCE, vol.36, p.227, 2006.
Left ventricular hypertrophy. Epidemiological insights from the Framingham Heart Study, Drugs, vol.35, pp.1-5, 1988. ,
Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until, Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -Eur Ren Assoc. mars, vol.13, issue.3, pp.564-573, 1996. ,
Prognostic implications of left ventricular hypertrophy, Am Heart J. mars, vol.141, issue.3, pp.334-375, 2001. ,
Diastolic Dysfunction and Hypertension, Med Clin North Am. janv, vol.101, issue.1, pp.7-17, 2017. ,
The pathogenesis of acute pulmonary edema associated with hypertension, N Engl J Med, vol.344, issue.1, pp.17-22, 2001. ,
Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE), Cell Electrophysiol Eur Soc Cardiol. 1 juin, vol.19, issue.6, pp.891-911, 2017. ,
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study, Lancet Lond Engl. 10 juill, vol.376, issue.9735, pp.112-135, 2010. ,
Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study, Am J Epidemiol. 15 sept, vol.138, issue.6, pp.353-64, 1993. ,
, The Association Between Midlife Blood Pressure Levels and Late-Life Cognitive Function. The Honolulu-Asia Aging Study -PubMed
Elevated Blood Pressure and Risk of End-stage Renal Disease in Subjects Without Baseline Kidney Disease, Arch Intern Med. 25 avr, vol.165, issue.8, p.923, 2005. ,
Hypertensive Kidney Injury and the Progression of Chronic Kidney Disease, Hypertension, vol.70, issue.4, pp.687-94, 2017. ,
Impaired autoregulation of GFR in hypertensive noninsulin dependent diabetic patients. Kidney Int, vol.52, pp.1369-74, 1997. ,
Impaired autoregulation of the glomerular filtration rate in patients with nondiabetic nephropathies. Kidney Int, vol.56, pp.1517-1540, 1999. ,
Hospital admissions for hypertensive crisis in the emergency departments: a large multicenter Italian study, PloS One, vol.9, issue.4, p.93542, 2014. ,
Endothelial dysfunction, platelet activation, thrombogenesis and fibrinolysis in patients with hypertensive crisis, J Hypertens. mai, vol.29, issue.5, pp.922-929, 2011. ,
Hypertensive emergencies are associated with elevated markers of inflammation, coagulation, platelet activation and fibrinolysis, J Hum Hypertens. juin, vol.27, issue.6, pp.368-73, 2013. ,
Malignant hypertension: diagnosis, treatment and prognosis with experience from the Bordeaux cohort, J Hypertens, vol.37, issue.2, pp.316-340, 2019. ,
KDIGO clinical practice guidelines for acute kidney injury, Nephron Clin Pract, vol.120, issue.4, pp.179-184, 2012. ,
Decreased renal function in hypertensive emergencies, J Hum Hypertens. juill, vol.28, issue.7, pp.427-458, 2014. ,
, Shock Augusta Ga. mars, vol.45, issue.3, pp.259-70, 2016.
Renal autoregulation and blood pressure management in circulatory shock, Crit Care, vol.22, 2018. ,
Hypertensive emergencies: an update, Curr Opin Crit Care. déc, vol.17, issue.6, pp.569-80, 2011. ,
Antihypertensive therapy with nicardipine for patients with aortic disease is associated with more esmolol usage than urapidil, J Thorac Dis. déc, vol.6, issue.12, pp.1765-71, 2014. ,
,
, Rev Pneumol Clin. juin, vol.68, issue.3, pp.221-225, 2012.
Effect of nicardipine hydrochloride on regional hypoxic pulmonary vasoconstriction, Br J Anaesth. avr, vol.60, issue.5, pp.547-54, 1988. ,
, Rapidly Reversible Hypoxemia in the Early Period after Bilateral Lung Transplantation, vol.13, pp.979-85, 2016.
Effects of antihypertensive drugs on autoregulation of RBF and glomerular capillary pressure in SHR, Am J Physiol, vol.275, issue.4, pp.576-584, 1998. ,
Urapidil, but not dihydropyridine calcium channel inhibitors, preserves the hypoxic pulmonary vasoconstriction: an experimental study in pig arteries, Fundam Clin Pharmacol, vol.33, issue.5, pp.527-561, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02322364
compared to nitroglycerin, has better clinical safety in the treatment of hypertensive patients with acute heart failure: a meta-analysis, Drug Des Devel Ther, vol.13, pp.161-72, 2019. ,
Therapeutic effects of intravenous urapidil in elderly patients with hypertension and acute decompensated heart failure: A pilot clinical trial, Exp Ther Med. juill, vol.12, issue.1, pp.115-137, 2016. ,
A systematic review of nicardipine vs labetalol for the management of hypertensive crises, Am J Emerg Med. juill, vol.30, issue.6, pp.981-93, 2012. ,
Enhancing Recovery From Sepsis: A Review, JAMA, vol.319, issue.1, pp.62-75, 2018. ,
Impact of post-sepsis cardiovascular complications on mortality in sepsis survivors: a population-based study, Crit Care Lond Engl. 2 sept, vol.23, issue.1, p.293, 2019. ,
Long-Term Mortality and Major Adverse Cardiovascular Events in Sepsis Survivors. A Nationwide Population-based Study, Am J Respir Crit Care Med, vol.15, issue.2, pp.209-226, 2016. ,
Acute Severe Hypertension. Solomon CG, éditeur, N Engl J Med, vol.381, pp.1843-52, 2019. ,
Design of Clinical Trials in Acute Kidney Injury: Report from an NIDDK Workshop on Trial Methodology, Clin J Am Soc Nephrol. 1 mai, vol.7, issue.5, pp.844-50, 2012. ,
Identification of Major Adverse Kidney Events Within the Electronic Health Record, J Med Syst. juill, vol.40, issue.7, p.167, 2016. ,
ESC Council on hypertension position document on the management of hypertensive emergencies, Eur Heart J Cardiovasc Pharmacother, vol.01, issue.1, pp.37-46, 2019. ,
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and metaanalysis, The Lancet. mars, vol.387, pp.957-67, 2016. ,
,
, Au moment d'être admis à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité
, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux, individuels et sociaux
, Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité. Même sous la contrainte
, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir hérité des circonstances pour forcer les consciences
, Je ne me laisserai pas influencer par la soif du gain ou la recherche de la gloire
, Reçu à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs
, Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément
, Je n'entreprendrai rien qui dépasse mes compétences. Je les entretiendrai et les perfectionnerai pour assurer au mieux les services qui me seront demandés
, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité
, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses
, que je sois déshonoré et méprisé si j'y manque